Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
QuintilesIMS
Moodys
Fish and Richardson
Accenture
Medtronic
Argus Health
Covington
Cantor Fitzgerald
US Department of Justice

Generated: January 20, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,251,091

« Back to Dashboard

Summary for Patent: 6,251,091
Title: Needleless injector drug capsule and filling method
Abstract:A needleless injector capsule for a liquid medicament has a filling adaptor removably, and preferably frangibly, attached thereto. The capsule has a chamber for receiving injectate, the chamber being provided with an injection orifice, and having a piston located for movement therein. The adaptor has a bore which communicates with the capsule chamber via the injection orifice. The capsule is filled by introducing injectate into the capsule chamber through the injection orifice and excess injectate into bore of the adaptor, and closing the bore of the adaptor to the exterior by a sealing means, leaving the bore partly filled with excess injectate.
Inventor(s): Weston; Terence Edward (Eye, GB)
Assignee: Weston Medical Limited (Eye, GB)
Application Number:09/091,320
Patent Claim Types:
see list of patent claims
Dosage form; Use;

Drugs Protected by US Patent 6,251,091

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Endo Ventures Ltd SUMAVEL DOSEPRO sumatriptan succinate INJECTABLE;SUBCUTANEOUS 022239-001 Jul 15, 2009 BX RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 6,251,091

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9525757Dec 16, 1995
PCT Information
PCT FiledDecember 09, 1996PCT Application Number:PCT/GB96/03017
PCT Publication Date:June 26, 1997PCT Publication Number: WO97/22375

International Patents Family Members for US Patent 6,251,091

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 204772 ➤ Subscribe
Australia 1102397 ➤ Subscribe
Australia 4935800 ➤ Subscribe
Brazil 9612003 ➤ Subscribe
Canada 2240581 ➤ Subscribe
Germany 69614881 ➤ Subscribe
Denmark 0876175 ➤ Subscribe
European Patent Office 0876175 ➤ Subscribe
European Patent Office 1097727 ➤ Subscribe
European Patent Office 1180046 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKesson
Cerilliant
UBS
Baxter
Deloitte
Colorcon
US Army
Boehringer Ingelheim
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot